Key Eligibility Criteria for This Study

To be eligible for the study, the patient must

  • Be at least 18 years of age
  • Have a documented history of at least 2 previous episodes of Clostridium difficile infection in the last 12 months and currently experiencing an active C. diff infection

Study participation will also depend on other requirements which will be determined at the screening visit.

Can I Take Part?


  • Seres Therapeutics (Study Protocol, 20170324 Poster English20170324V1SERES-012RecruitmentBrochureEnglishCMcG, Seres 012PosterEnglish CLIENT REV & QD TRKED.DOCX)